On the Role of Artificial Intelligence in Genomics to Enhance Precisio | PGPM – Dove Medical Press

scar lvarez-Machancoses,1,2 Enrique J DeAndrs Galiana,1 Ana Cernea,1 J Fernndez de la Via,1 Juan Luis Fernndez-Martnez2

1Group of Inverse Problems, Optimization and Machine Learning, Department of Mathematics, University of Oviedo, Oviedo 33007, Spain; 2DeepBiosInsights, NETGEV (Maof Tech), Dimona 8610902, Israel

Correspondence: Juan Luis Fernndez-MartnezGroup of Inverse Problems, Optimization and Machine Learning, Department of Mathematics, University of Oviedo, C. Federico Garca Lorca, 18, Oviedo 33007, SpainEmail jlfm@uniovi.es

Abstract: The complexity of orphan diseases, which are those that do not have an effective treatment, together with the high dimensionality of the genetic data used for their analysis and the high degree of uncertainty in the understanding of the mechanisms and genetic pathways which are involved in their development, motivate the use of advanced techniques of artificial intelligence and in-depth knowledge of molecular biology, which is crucial in order to find plausible solutions in drug design, including drug repositioning. Particularly, we show that the use of robust deep sampling methodologies of the altered genetics serves to obtain meaningful results and dramatically decreases the cost of research and development in drug design, influencing very positively the use of precision medicine and the outcomes in patients. The target-centric approach and the use of strong prior hypotheses that are not matched against reality (disease genetic data) are undoubtedly the cause of the high number of drug design failures and attrition rates. Sampling and prediction under uncertain conditions cannot be avoided in the development of precision medicine.

Keywords: artificial intelligence, big data, genomics, precision medicine, drug design

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Visit link:

On the Role of Artificial Intelligence in Genomics to Enhance Precisio | PGPM - Dove Medical Press

Related Post

Comments are closed.